Preventing Immune Effector Cell-Associated Neurotoxicity Through Early Neurovascular Biomarker Surveillance

Speciality: Oncology

Description:

Today, let’s explore how early surveillance of neurovascular biomarkers can help prevent immune effector cell-associated neurotoxicity. This condition, known as ICANS, is a serious complication that can occur after treatments like CAR T-cell therapy. By carefully monitoring biomarkers—biological indicators in the blood or cerebrospinal fluid—clinicians can identify early signs of neurotoxicity before symptoms become severe. This proactive approach allows for timely interventions, potentially reducing the risk and severity of neurological side effects. Recent research highlights the importance of integrating biomarker surveillance into treatment protocols, paving the way for safer immunotherapy experiences. Through early detection and intervention, we can make immunotherapies safer and more effective for patients.

See More Webinars @ Hidoc Webinars